SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Petmed Express Inc. – ‘8-K’ for 5/3/21

On:  Wednesday, 5/5/21, at 2:56pm ET   ·   For:  5/3/21   ·   Accession #:  1437749-21-10871   ·   File #:  0-28827

Previous ‘8-K’:  ‘8-K’ on 5/4/21 for 5/3/21   ·   Next:  ‘8-K’ on 5/27/21 for 5/25/21   ·   Latest:  ‘8-K’ on / for 4/15/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/05/21  Petmed Express Inc.               8-K:2,9     5/03/21   12:186K                                   RDG Filings/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     23K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     24K 
 8: R1          Document And Entity Information                     HTML     46K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- pets20210505_8k_htm                 XML     13K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.DEF  XBRL Definitions -- pets-20210503_def                XML     37K 
 5: EX-101.LAB  XBRL Labels -- pets-20210503_lab                     XML     48K 
 6: EX-101.PRE  XBRL Presentations -- pets-20210503_pre              XML     36K 
 3: EX-101.SCH  XBRL Schema -- pets-20210503                         XSD     14K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
12: ZIP         XBRL Zipped Folder -- 0001437749-21-010871-xbrl      Zip     16K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C: 
 i false  i 0001040130 0001040130 2021-05-03 2021-05-03
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM  i 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported):  i May 3, 2021
 
 i PetMed Express, Inc.
 (Exact name of registrant as specified in its charter)
 
 i Florida
   
 i 65-0680967
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
 
 i 420 South Congress Avenue,  i Delray Beach,  i FL  i 33445
(Address of principal executive offices) (Zip Code)
 
 
( i 561)  i 526-4444
(Registrant’s telephone number, including area code)
 
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
 i 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 i 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 i 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 i 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
 i Common Stock, par value $.001 per share
 i PETS
 i NASDAQ Global Select Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  i 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 2.02   Results of Operations and Financial Condition.
 
On May 3, 2021, PetMed Express, Inc. (the “Company”) discussed its financial results for the quarter and fiscal year ended on March 31, 2021. A copy of this conference call transcript is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
 
The information in this Item 2.02 and the information contained in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any Company filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such filing.
 
Item 9.01   Financial Statements and Exhibits.
 
 
(d)
Exhibits.
     
   
104 – Cover Page Interactive Data File (formatted as Inline XBRL).
 
EXHIBIT INDEX
 
Exhibit No.
Description
   
99.1
PetMed Express, Inc. conference call transcript dated May 3, 2021.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: May 5, 2021
 
 
PETMED EXPRESS, INC.
     
 
By:
 
Name:
 
Title:
Chief Financial Officer
 
2
 
 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:5/5/21
For Period end:5/3/218-K
3/31/2110-K
 List all Filings 
Top
Filing Submission 0001437749-21-010871   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., Apr. 24, 10:27:54.1am ET